Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Keratosis, Actinic 5Carcinoma, Squamous Cell 2Squamous Intraepithelial Lesions 1Radiodermatitis 1Psoriasis 1Neoplasms 1Lymphoma, Follicular 1Carcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 76Radiotherapy 44pembrolizumab 39Cetuximab 38Paclitaxel 34Carboplatin 33Docetaxel 30Fluorouracil 25Radiotherapy, Intensity-Modulated 22Nivolumab 18Drug Therapy 14Radiation 12Erlotinib Hydrochloride 9cemiplimab 8Magnetic Resonance Spectroscopy 8130-nm albumin-bound paclitaxel 8durvalumab 7atezolizumab 7Cyclophosphamide 7Afatinib 7Surgical Procedures, Operative 6Panitumumab 6Leucovorin 6Chemoradiotherapy 6fludarabine 5aldesleukin 5Radiosurgery 5Oxaliplatin 5Methotrexate 5Gemcitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Squamous Cell × calcipotriene × Clear all
NCT03370406 2026-06-01

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

University of Pittsburgh

Phase 1 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT04839731 2023-02-13

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Carilion Clinic

Phase EARLY_PHASE1 Unknown
30 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡